Harvinder Deogun, MD
Physical Medicine & Rehabilitation · Scottsdale, AZNPI 1558568501
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $655 of the $836 with a category attached, or 78.4%. Biotronik NRO, Inc. accounts for 87.0% of it on its own, with 1 other manufacturer making up the rest.
Across 9 payments — averaging $92.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik NRO, Inc.$727
- Boston Scientific$109
Across 10 payments — averaging $4749.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$47K
What the payments were for
- Travel & lodging$65578%
- Food & beverage$18122%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik NRO, Inc. | 8 | $727 |
| Boston Scientific | 1 | $109 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOTRONIK$522
- GENERAL PAIN MANAGEMENT$109
How this compares
$836 in reported general payments places this provider in the 65th percentile of 162 physical medicine & rehabilitation providers in Arizona.
See all physical medicine & rehabilitation providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 104 | $966 |
| Tramadol Hcl | 112 | $638 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $581 |
| Tizanidine Hcl | 55 | $494 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $333 |
| Celecoxib | 13 | $330 |
| Cyclobenzaprine Hcl | 23 | $310 |
| Pregabalin | 20 | $257 |
| Oxycodone Hcl | 13 | $104 |
| Methylprednisolone | 15 | $104 |
| Meloxicam | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Scottsdale
- Jacob RohrsScottsdale$10K
- Paul OverdorfScottsdale$10K
- Estelle FarrellScottsdale$5K
- Joanna IsraelScottsdale$2K
- Cameron ForbesScottsdale$2K
- Allan RowleyScottsdale$2K
- Raj SinghScottsdale$1K
- Marshall MeierFlagstaff$63K
- Azmi NasserPhoenix$46K
- Christina KwasnicaPhoenix$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.